GP 127 (Metformin 850 mg)

Pill imprint GP 127 has been identified as Metformin hydrochloride 850 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GP 127

Metformin hydrochloride 850 mg GP 127
Metformin hydrochloride 850 mg GP 127
Metformin hydrochloride
Imprint:
GP 127
Strength:
850 mg
Color:
White
Size:
13.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5051
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
polyethylene glycol
polysorbate 80
povidone
sodium starch glycolate type A potato
corn starch
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-5850 Major Pharmaceuticals
67544-1383 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)